WCG Expert to Lead Human Gene Transfer Educational Course at the ABSA Annual Biological Safety Conference
Course will cover the latest applications of synthetic biology in clinical research and help IBC members prepare to review gene therapy protocols.
WCG Clinical Services Division Partners with Inspire to Improve Patient Recruitment in Clinical Trials
WCG gains premier access to leading healthcare social network, taps highly engaged patients for trial participation and patient-centric medicine Princeton, NJ – September 4, 2018 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division has partnered with Inspire, the largest online community of patients and caregivers, to make clinical research more accessible to all patients, especially […]
The addition of KMR Group and MCC positions WCG’s Market Insights and Intelligence Division as the preeminent clinical trial benchmarking and research service in the industry.
WCG Clinical Services Division Partners with InformedDNA to Help Sponsors Design and Execute More Effective Clinical Trials
Companies join forces to deliver new solutions that optimize genetics in clinical trials in the era of precision medicine
WCG expands global clinical research support presence
WCG Clinical Services Division expands portfolio to include the industry leader in Endpoint Adjudication and Data Monitoring Safety Committees Princeton, NJ – Mar. 27, 2018 – WCG™ (WIRB-Copernicus Group®) Clinical Services Division, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of ACI Clinical, […]
2017 was a fascinating year for those of us closely following the clinical research industry. And 2018 promises not to disappoint. Within the WIRB-Copernicus Group (WCG) family of companies, our subject matter experts are always watching regulatory, technology, and practice trends. Their observations, combined with a deep understanding of the science and practice of clinical […]
WCG expands portfolio to include top pharmacovigilance, drug safety solution provider Princeton, NJ – Nov. 28, 2017 – WIRB Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of Vigilare International, the top provider of integrated, end-to-end pharmacovigilance and drug safety […]
WCG will create a seamless connection between WCG’s MyConnexus™ IRB document management web portal and Veeva Vault eTMF PRINCETON, N.J., Nov. 16, 2017 /PRNewswire/ — WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems Inc. to improve the speed and […]
WCG’s MedAvante-ProPhase Adds Business Leaders to Expand Offerings, Increase Client Success in CNS, Mental Health
Industry experts will help to drive company’s growth in central nervous system (CNS) and behavioral health assessment markets Princeton, NJ – August 15, 2017 – WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced today that industry experts Steven Herne and Michael Cioffi have joined […]